1201 D3 ECP
BioCentury & Getty Images

Emerging Company Profile

How D3 Bio is building its biomarker-driven pipeline

Emerging Company Profile: D3 Bio’s Chen on the start-up’s internal pipeline, plans for in-licensing

D3 Bio’s George Chen on the Shanghai start-up’s internal pipeline and plans for in-licensing.

Dec 9, 2020 | 12:08 AM GMT

George Chen’s D3 Bio is prioritizing  its internal pipeline so it can be choosy about

Read the full 649 word article

How to gain access

Continue reading with a
two-week free trial.